title: ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
abstract: This guideline is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Adherence to this guideline should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The topics dealt with in this guideline include indications for the use of iodine-131, both for the treatment of hyperthyroidism and thyroid carcinoma. In addition, indications for other less common procedures include those for the use of phosphorous-32 in its liquid and colloidal forms, strontium-89, samarium-153, and the use of Y-90 antibodies.
authors.affiliation: Department of Nuclear Medicine, Loyola University Medical Center, Maywood, IL, USA.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Henkin
authors.forename: John D
authors.initials: JD
authors.lastname: Del Rowe
authors.forename: Perry W
authors.initials: PW
authors.lastname: Grigsby
authors.forename: Alan C
authors.initials: AC
authors.lastname: Hartford
authors.forename: Hossein
authors.initials: H
authors.lastname: Jadvar
authors.forename: Roger M
authors.initials: RM
authors.lastname: Macklis
authors.forename: J Anthony
authors.initials: JA
authors.lastname: Parker
authors.forename: Jeffrey Y C
authors.initials: JY
authors.lastname: Wong
authors.forename: Seth A
authors.initials: SA
authors.lastname: Rosenthal
mesh_terms: D055011:Ablation Techniques; D001201:Ascites / Q000532:radiotherapy; D001859:Bone Neoplasms / Q000150:complications / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D004282:Documentation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000532:radiotherapy; D017053:Infection Control; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010146:Pain / Q000209:etiology / Q000532:radiotherapy; D010353:Patient Education as Topic; D010996:Pleural Effusion / Q000532:radiotherapy; D011087:Polycythemia Vera / Q000150:complications / Q000532:radiotherapy; D011184:Postoperative Period; D011786:Quality Control; D018787:Radiation Oncology / Q000592:standards*; D016499:Radioimmunotherapy; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects / Q000592:standards*; D012449:Safety; D012955:Societies, Medical; D013922:Thrombocytosis / Q000150:complications; D013964:Thyroid Neoplasms / Q000532:radiotherapy
chemical_list: D019275:Radiopharmaceuticals